Stockreport

Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares

Eupraxia Pharmaceuticals Inc.  (EPRX) 
PDF VICTORIA, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage b [Read more]